Colloidal Silver: A Natural Anti-Viral Agent
Despite the FDA’s reluctance to recognize colloidal silver as an anti-viral agent, various studies have demonstrated its potential in combating viruses. A study published in the journal Nanobiotechnology in June 2005 revealed that nanosilver, a form of colloidal silver, exhibited inhibitory effects against HIV-1 in test tubes. The experiment involved exposing the HIV-1 virus to white blood cells and silver nanoparticles, which effectively prevented the virus from binding to the cells. Additionally, a study published in the Pharmaceutical Chemistry Journal in 1992 highlighted the effectiveness of colloidal silver, specifically Protargol, against the smallpox virus. The use of Protargol resulted in a significant reduction in viral particles by 700 times, while the application of Collargol silver colloidal led to an impressive 11,000 times reduction in the smallpox viral load.
The Power of Silver as a Natural Antibacterial Agent
According to the US National Library of Medicine, silver has long been recognized for its remarkable antibacterial properties. In fact, its effectiveness against bacteria is significantly higher than its toxicity towards human cells. Although the exact mechanisms by which silver kills bacteria are not fully understood, numerous studies have demonstrated that silver nanoparticles ranging from 1 to 100 nm in size are particularly effective in combating bacterial infections. One example of the practical application of silver’s antibacterial power is silver sulfadiazine, a topical colloidal silver variant that has been proven to successfully fight off harmful bacteria.